PACKAGE LEAFLET: INFORMATION FOR THE USER. altavitad3 25,000 IU oral solution colecalciferol

Similar documents
THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Fultium can also be used as an adjunct to specific bone loss medication

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Vitamin D deficiency: Altavita D3 - A range designed for compliance

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

ANBESOL TM Anaesthetic Antiseptic Oromucosal solution Lidocaine hydrochloride 0.90%w/w, Chlorocresol 0.10%w/w, Cetylpyridinium Chloride 0.

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Summary of Product Characteristics

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the patient

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user. Calcichew-D 3 Citron 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package Insert. D-Bright

1. What Octostim Nasal Spray is and what it is used for

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Each 100,000 IU capsule contains 0.02 mg Allura Red AC (E129) and 0.12 mg Sunset Yellow FCF (E110)

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the use. Calcichew-D3 Citron 500 mg/400 IU chewable tablets calcium / cholecalciferol (vitamin D3)

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

SUMMARY OF PRODUCT CHARACTERISTICS. A 2.5ml single-dose bottle containing IU Cholecalciferol (equivalent to 625 micrograms vitamin D 3 )

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

1. What Faslodex is and what it is used for

1. What Betahistine dihydrochloride tablets is and what it is used for

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Carmellose sodium

Echinaforce Hot Drink

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the patient

2 What you need to know before you use Zofran Suppositories

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Echinaforce Cold & Flu oral drops Echinacea purpurea herb & root tinctures

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Pravat 40 mg tablets. Pravastatin sodium

Package leaflet: Information for the user

Package Leaflet: Information for the user. Digestisan oral drops

1. What Miacalcic is and what it is used for

Ascorbic Acid. Dr. Scheffler Vitamin C effervescent tablets are used for the treatment of vitamin C deficiency diseases (e. g. scurvy).

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

Package leaflet: Information for the user. Recikalc-D forte 500 mg/800 IU chewable tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

PATIENT INFORMATION LEAFLET

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the patient. Symkevi 100 mg/150 mg film-coated tablets tezacaftor/ivacaftor

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Irbenida H 150mg/12,5mg film-coated tablets

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Sibelium 5 mg Tablets flunarizine

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER altavitad3 25,000 IU oral solution colecalciferol Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further quest ions, ask your doctor or pharmacist, or nurse. - This medicine has been prescribed for you only. Do not pass it onto others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What altavitad3 is and what it is used for 2. What you need to know before you use altavitad3 3. How to use altavitad3 4. Possible side effects 5. How to store altavitad3 6. Contents of the pack and other informat ion 1. WHAT ALTAVITAD3 IS AND WHAT IT IS USED FOR altavitad3 is a vitamin product containing colecalciferol (equivalent to vitamin D 3 ). Vitamin D can be found in some foods and also produced by the body when skin is exposed to sunlight. Vitamin D helps the kidneys and intestine absorb calcium and it helps build bones. altavitad3 25,000 IU is used: - for the prevent ion of vitamin D deficiency when there is a significant risk of deficiency or an increased demand for vitamin D - with other medicines to treat certain bone condit ions, such as thinning of the bone (osteoporosis) - to treat vitamin D deficiency that has been confirmed by laboratory tests. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE ALTAVITAD3 Do not use altavitad3 - if you are allergic to vitamin D or any of the other ingredients of altavitad3 (listed in section 6) - if you have hypercalcaemia (high levels of calcium in the blood) - if you have hypercalciuria (high levels of calcium in the urine) - if you have pseudohypoparathyroidism (disturbed parathyro id hormone metabo lism) - if you have renal calculi (kidney stones) - if you have hypervitaminosis D (high levels of vitamin D in the blood). Warnings and precautions Talk to your doctor, pharmacist or nurse before using altavitad3 if you: - are undergoing treatment with certain medicines used to treat heart disorders (e.g., cardiac glycosides, such as digoxin) 1

- have sarcoidosis (an immune system disorder which may cause increased levels of vitamind in the body) - are taking medicines containing vitamin D, or eating foods or milk enriched with vitamin D - are likely to be exposed to a lot of sunshine whilst using altavitad3 - take addit ional supplements containing calcium. Your doctor will monitor your blood levels of calcium to make sure they are not too high whilst you are using altavitad3 - have kidney damage or disease. Your doctor may want to measure the levels of calcium in your blood or urine. Other medicines and altavitad3 Tell your doctor or pharmacist if you are using, have recent ly used or might use any other medicines. This is especially important if you are taking: - medicines that act on the heart or kidneys, such as cardiac glycosides (e.g. digoxin) or diuret ics (e.g. bendroflumethazide). When used at the same time as vitamin D these medicines may cause a large increase in the level of calcium in the blood and urine - medicines containing vitamin D or eating food rich in vitamin D, such as, some types of vitamin D-enriched milk - actino mycin (a medicine used to treat some forms of cancer) and imidazo le antifungals (e.g. clotrimazole and ketoconazole, medicines used to treat fungal disease). These medicines may interfere with the way your body process vitamin D - the fo llowing medicines because they can interfere with the effect or the absorption of vitamin D: - ant iepilept ic medicines (anticonvulsants), barbiturates - glucocortico ids (steroid hormones such as hydrocortisone or predniso lone). These can decrease the effect of vitamin D - medicines that lower the level of cholesterol in the blood (such as cho lest yramine, or colestipo l) - certain medicines for weight loss that reduce the amount of fat your body absorbs (e.g. orlistat) - certain laxat ives (such as liquid paraffin). altavitad3 with food, drink and alcohol You should take this medicine preferably together with a large meal to help your body absorb the vitamin D. You can also mix the so lut ion with cold or lukewarm food, to help you take this medicine. For detailed informat ion see section 3 How to use altavitad3. Pregnancy, breast-feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. This high strength formulat ion is not recommended for use in pregnant and breast feeding women. Driving and using machines There is limited information on the possible effects of this medicine on your abilit y to drive. However, it is not expected that it would affect your abilit y to drive or to operate machinery. 3. HOW TO USE ALTAVITAD3 Always take altavitad3 exact ly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. You should take altavitad3 preferably together with a large meal. 2

This medicine has a delicate taste of olive oil. The contents of the single-dose oral solution is to be empt ied direct ly into the mouth and swallowed orally as per the diagram below. To help you take this medicine, the full contents of the single-dose oral solution may be emptied onto a spoon and taken orally. You may also mix the contents of the single-dose oral solution with a small amount of cold or lukewarm food immediately before use. Make sure the entire dose is taken. Use in children and adolescents The recommended dose for: - Prevention of vitamin D deficiency in 0-1 years: 1 single-dose oral solution of altavitad3 25,000 IU every 8 weeks - Prevention of vitamin D deficiency in 1-18 years: 1 single-dose oral solution of altavitad3 25,000 IU every 6 weeks - Treatment of vitamin D deficiency in 0-18 years: 1 single-dose oral solution of altavitad3 25,000 IU once every 2 weeks for 6 weeks (fo llowed by maintenance therapy of 400-1000 IU/day), such as 25,000 IU (1 single-dose oral solution) per month In children, altavitad3 can be mixed with a small amount of children s foods, yogurt, milk, cheese or other dairy products. Do not mix this medicine into a bottle of milk or container of soft food, in case your child does not consume the who le portion, and does not receive the full dose. You should make sure that the entire dose is taken. For children who are no longer being breast fed you should give the prescribed dose with a meal. Do not store any product or food mixture that contains altavitad3 for use at a later time or a next meal. Use in pregnancy and breast-feeding This high strength formulat ion is not recommended. Use in adults The recommended dose for: - Prevention of vitamin D deficiency: 1 single-dose oral solution of altavitad3 25,000 IU per month. Higher doses may be required based on the advice of your doctor. - Addition to specific therapy for osteoporosis: 1 single-dose oral solution of altavitad3 25,000 IU per month. 3

- Treatment of vitamin D deficiency: 2 single-dose oral solutions of altavitad3 25,000 IU once weekly for 6-8 weeks, followed by maintenance therapy (1400-2000 IU /day such as 50,000 IU (2 single-dose oral solutions) per month may be required), based on the advice of your doctor. If you take more altavitad3 than you should If you or your child takes more medicine than prescribed, stop using this medicine and contact your doctor. If it is not possible to talk to a doctor, go to the nearest hospital emergency department and take the medicine package with you. The most common symptoms of overdose are: nausea, vomit ing, excessive thirst, the production of large amounts of urine over 24 hours, constipation and dehydrat ion, high levels of calcium in the blood (hypercalcaemia and hypercalciuria) shown by lab test. If you forget to take altavitad3 If you forget to take a dose of altavitad3, take the forgotten dose as soon as possible. Then take the next dose at the correct time. However, if it is almost time to take the next dose, do not take the dose you have missed; just take the next dose as normal. Do not take a double dose to make up for a forgotten dose. If you have any further quest ions on the use of this medicine, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, this medicine can cause side effects, although not everybody gets them. Possible side effects may include: Uncommon (may affect up to 1 in 100 people) - Too much calcium in your blood (hypercalcaemia) - Too much calcium in your urine (hypercalciuria) Rare (may affect up to 1 in 10,000 people) - Skin rash - Itching - Hives Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL Dublin 2; Tel: + 353 1 6764971; Fax: + 353 1 6762517. Website: www.hpra.ie; Email: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE ALTAVITAD3 Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and single-dose oral solution after Exp. The expiry date refers to the last day of that month. Do not store above 30 C. 4

Store altavitad3 in the original carton to protect the contents from light. If the oral solution within the single-dose oral solution is discoloured or show signs of any deterioration, you should seek the advice of your pharmacist. Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION What altavitad3 contains - The act ive substance is colecalciferol (vitamin D 3 ). - Each single-dose oral solution contains 0.625 mg colecalciferol, equivalent to 25,000 IU vitamin D. - The other ingredients are tocopherol acetate, polyglyceryl o leate (E475), olive oil, refined, sweet orange peel oil. What altavitad3 looks like and contents of the pack altavitad3 is a clear, slight ly yellow, oily liquid. It is supplied in transparent PVC/PVDC/PE single-dose oral solution. altavitad3 is available in packs of 3 PVC/PVDC/PE single-dose oral solutions. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorization Holder Consilient Health Limited, 5 th Floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland. Manufacturer SMB Techno logy S.A. 39, rue du parc industriel 6900 Marche en Famenne Belgium. This leaflet was last revised in March 2017. 5